Urine-Derived Induced Pluripotent Stem Cells in Cardiovascular Disease. (10th January 2020)

• Record Type: Journal Article
• Authors: Huang, Ping; Li, Yibin; Nasser, M. I.; Guo, Huiming; Huang, Huanlei; Zhao, Mingyi; Zhu, Ping
• Other Names: Wolin Michael S. Academic Editor.
• Is Part Of: Cardiology research and practice. Volume 2020(2020)
• Publication Date: 2020-01-10
• Subjects: Cardiology -- Research -- Periodicals; Cardiology -- Periodicals; Cardiology; Cardiology; Cardiology -- Research; Electronic journals; Periodicals; Periodicals; 616.12
• DOI: 10.1155/2020/3563519
• Languages: English
• ISSNs: 2090-8016

Abstract

Abstract : Recent studies have demonstrated that stem cells are equipped with the potential to differentiate into various types of cells, including cardiomyocytes. Meanwhile, stem cells are highly promising in curing cardiovascular diseases. However, owing to the ethical challenges posed in stem cell acquisition and the complexity and invasive nature of the method, large-scale expansions and clinical applications in the laboratory have been limited. The current generation of cardiomyocytes is available from diverse sources; urine is one of the promising sources among them. Although advanced research was established in the generation of human urine cells as cardiomyocytes, the reprogramming of urine cells to cardiomyocytes remains unclear. In this context, it is necessary to develop a minimally invasive method to create induced pluripotent stem cells (iPSCs). This review focuses on the latest advances in research on urine-derived iPSCs and their application mechanisms in cardiovascular diseases.